Antje Zeise - Epigenomics AG Insider

Manager Investor Relations

We currently do not have informatin regarding Antje Zeise. This executive tanure with Epigenomics AG is not currenlty determined.
        
49 30 243 450  http://www.epigenomics.de

Management Efficiency

The company has return on total asset (ROA) of (25.16) % which means that it has lost $25.16 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE) of (70.57) % meaning that it generated substantial loss on money invested by shareholders.

Similar Executives

Showing few of many executives

EXECUTIVE Since

Deyan WengCathay Financial Holding Co Ltd
N/A
Sabirin SaimanPT AKR Corporindo Tbk
1994
YuChin ChengCathay Financial Holding Co Ltd
2015
Bocang XieCathay Financial Holding Co Ltd
2013
Weizheng LiCathay Financial Holding Co Ltd
2008
Harryati UtamiPT AKR Corporindo Tbk
2009
Heri AkhyarPT AKR Corporindo Tbk
N/A
I MastraPT AKR Corporindo Tbk
2009
Francis PengCathay Financial Holding Co Ltd
2016
Chongyi DengCathay Financial Holding Co Ltd
2013
PoTsang HsiehCathay Financial Holding Co Ltd
2013
Jun ChoiSK Innovation
2014
DehYen WengCathay Financial Holding Co Ltd
2011
Shuguang ZhangCathay Financial Holding Co Ltd
2015
Daqing HongCathay Financial Holding Co Ltd
2013
Chaoji CaiCathay Financial Holding Co Ltd
N/A
Nyoman MastraPT AKR Corporindo Tbk
2009
Shaozhou HuangCathay Financial Holding Co Ltd
N/A
Chaoxiang LinCathay Financial Holding Co Ltd
2015
HsiaoYuan ChingCathay Financial Holding Co Ltd
2015
Yoshiharu ShimataniKDDI Corp
N/A

Entity Summary

Epigenomics AG, a molecular diagnostics company, engages in developing and commercializing a pipeline of proprietary solutions for screening and diagnosis of cancer in Europe, North America, and internationally. Epigenomics AG [EPGNF] is a Pink Sheet which is traded through a dealer network over-the-counter (OTC).

Did you try this?

Run Insider Screener Now
   

Insider Screener

Find insiders across different sectors to evaluate their impact on performance
Hide  View All  Next  Launch Insider Screener
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Epigenomics AG to your portfolio

Top Management

Epigenomics AG Leadership Team
Albert Weber, President
Antje Zeise, Executive
Guenther Reiter, Executive
Gregory Hamilton, CEO, MBA
Ann Kessler, Executive
Heino Prondzynski, Chairman
Thomas Taapken, CFO
Annett Dietrich, Executive
Noel Doheny, CEO
Nicola HennebergBusse, President
Uwe Staub, President, Ph.D
Peter Vogt, Executive

Stock Performance

Epigenomics AG Performance Indicators